Human embryo implantation is a three-stage process (apposition, adhesion and invasion) invol-ving synchronized crosstalk between a receptive en-dometrium and a functional blastocyst. This ovarian steroid-dependant phenomenon can only take place during the window of implantation, a self-limited period of endometrial receptivity spanning between days 20 and 24 of the menstrual cycle. Implantation involves a complex sequence of signalling events, consisting in the acquisition of adhesion ligands together with the loss of inhibitory components, which are crucial to the establishment of pregnancy. Histological evaluation, now considered to add little clinically significant information, should be replaced by functional assessment of endometrial receptivity. Endometrial receptivity plays a crucial role in the establishment of a healthy pregnancy in cycles of assisted reproduction. Endometrial receptivity disor-der requires a personalized approach to each patient.
ВОЗ. План действий по охране сексуального и репродуктивного здоровья в поддержку выполнения Повестки дня в области устойчивого развития на период до 2030 г. в Европе – никого не оставить без внимания. Копенгаген, Дания: Европейский региональный комитет ВОЗ, шестьдесят шестая сессия, 2016. 34 с.
Margalioth EJ, Ben-Chetrit A, Gal M, Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod. (2006) 21:3036-43. doi: 10.1093/humrep/del305
PubMed Abstract | CrossRef Full Text | Google Scholar.
Hviid M.M., Macklon N. Immune modulation treatments-where is the evidence? Fertil Steril. (2017) 107:1284-93. doi: 10.1016/j.fertnstert.2017.04.009
PubMed Abstract | CrossRef Full Text | Google Scholar.
Evers JLHH. Is RIF rife? Hum Reprod. (2016) 31:2661. doi: 10.1093/humrep/dew277
PubMed Abstract | CrossRef Full Text | Google Scholar.
Hull K.L., Harvey S. Growth hormone and reproduction: a review of endocrine and autocrine/ paracrine interactions. Int J Endocrinol. (2014) 2014:234014. doi: 10.1155/2014/234014
Van den Boogaard E., Hermens R.P.M.G., Franssen A.M.H.W., Doornbos J.P.R., Kremer J.A.M., van der Veen F., Goddijn M. Recurrent miscarriage: do professionals adhere to their guidelines. Human Reproduction. 2013. vol.28. no. 11. Р. 2898–2904.
Mak W. BMJ Best Practice topic. Yale Recurrent Pregnancy Loss Program. Yale School of Medicine, New Haven, CT. 2017. 46 p.
Jeve Y.B., Davies W. Evidence-based management of recurrent miscarriages. J. Hum. Reprod. Sci. 2014. vol. 7. no. 3. P. 159–169. DOI: 10.4103/0974-1208.142475.
Regan L., Backos M., Rai R. The Investigation and Treatment of Couples with Recurrent First trimester and Second-trimester Miscarriage. RCOG Green-top Guideline No. 17. London. 2011. 18 p.
Федеральные клинические рекомендации «Выкидыш в ранние сроки беременности: диагностика и тактика ведения (протокол лечения) (2016). М., 2016. 32 с.
Grimbizis G., King B., Viora E., Colacurci N. Recurrent pregnancy loss. Guideline of the European Society of Human Reproduction and Embryology. ESHRE Early Pregnancy Guidline Development Group. 2017. 153 р.
Lucas E.S., Dyer N.P., Murakami K., Lee Y.H., Chan Y.W., Grimaldi G., Muter J., Brighton P.J., Moore J.D., Patel G., Chan J.K., Takeda S., Lam E.W., Quenby S., Ott S., Brosens J.J. Loss of Endometrial Plasticity in Recurrent Pregnancy Loss. Stem Cells. 2016. vol. 34. P. 346-356.
Mahajan N. Endometrial receptivity array: Clinical application. J. Hum. Reprod. Sci. 2015. vol. 8. P. 121-129.